HER2 Amplification and Breast Cancer Part 2
HTML-код
- Опубликовано: 9 ноя 2014
- In this video we look at how an amplification of the Her2 gene can constitute a gain of function mutation in the Her2 gene and how this can lead to breast cancer. We also look at the drug Trastuzumab/Herceptin.
Brilliant just brilliant...
HER2 is an orphan receptor so the EGF can't bind to HER2. It binds to anothor erbB receptor leading to its dimerisation with HER2.